Loading...
Health Advance Inc.
HADV•PNK
HealthcareMedical - Pharmaceuticals
$0.00
$-0.00(-25.00%)
Health Advance Inc. (HADV) Financial Performance & Statements
Review Health Advance Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
0.00%
Operating Income Growth
82.14%
↑ 82.14%
Net Income Growth
81.82%
↑ 81.82%
Operating Cash Flow Growth
95.74%
↑ 95.74%
Operating Margin
0.00%
Gross Margin
0.00%
Net Profit Margin
0.00%
ROE
82.53%
↑ 82.53%
ROIC
-29.06%
↓ 29.06%
Health Advance Inc. (HADV) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Health Advance Inc. stock.
| Metric | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $10938.00 | $11008.00 | $15351.00 | $10271.00 |
| Operating Expenses | $10938.00 | $11008.00 | $15351.00 | $10271.00 |
| Total Costs & Expenses | $10938.00 | $11008.00 | $15351.00 | $10271.00 |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $68.00 | $468.00 | $442.00 | $84.00 |
| Depreciation & Amortization | -$46.00 | $0.00 | $43276.00 | $43812.00 |
| EBITDA | -$10986.00 | -$11010.00 | -$15350.00 | -$10514.00 |
| EBITDA Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | -$10940.00 | -$11010.00 | -$15350.00 | -$10270.00 |
| Operating Income Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| Other Income/Expenses (Net) | -$115.00 | -$514.00 | -$498.00 | -$324.00 |
| Income Before Tax | -$11055.00 | -$11524.00 | -$15848.00 | -$10594.00 |
| Income Before Tax Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| Income Tax Expense | -$11055.00 | $0.00 | -$43277.00 | -$43812.00 |
| Net Income | -$11055.00 | -$11524.00 | -$15848.00 | -$10594.00 |
| Net Income Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| EPS | -$0.00 | -$0.00 | -$0.00 | -$0.00 |
| Diluted EPS | -$0.00 | -$0.00 | -$0.00 | -$0.00 |
| Weighted Avg Shares Outstanding | $185.95M | $185.95M | $185.95M | $185.95M |
| Weighted Avg Shares Outstanding (Diluted) | $185.95M | $185.95M | $185.95M | $185.95M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan